GlassScriptPhysician profile
Holley E Noble
NPI 1770117863
$487.56
in general payments reported to CMS, 2019-2025
10 companies · $71.34 in 2025
The $71.34 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $85.52 · 2022: $117 · 2023: $68.03 · 2024: $145 · 2025: $71.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $193.30 | 2022-2025 | |
| Agiliti Health, INC. | $52.14 | 2024-2025 | Sonablate Hifu, Siemens Healthineer Varian Intelliblate Microwave Ablation, Siemens Healthineers Varian Cryocare |
| 180 Medical, INC. | $51.21 | 2021-2022 | |
| Axonics, INC. | $44.13 | 2023 | Bulkamid |
| Abbvie INC. | $37.98 | 2024 | |
| Blue Earth Diagnostics | $30.10 | 2021 | |
| Teleflex LLC | $27.38 | 2024 | Urolift |
| Janssen Biotech, INC. | $24.66 | 2022 | |
| Clarus Therapeutics INC. | $13.65 | 2021 | |
| Boston Scientific Corporation | $13.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holley Noble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.